Methods and Systems for Preventing Diversion Of Prescription Drugs

• US 20080059226A1
• Filed: 09/20/2005
• Published: 03/06/2008
• Est. Priority Date: 09/20/2004
• Status: Abandoned Application

• Current Assignee: University of Florida Research Foundation, Incorporated (State University System of Florida)
• Original Assignee: University of Florida Research Foundation, Incorporated (State University System of Florida)
• Inventors: Melker, Richard, Gold, Mark
• Application Number:
  US11/578,322
• Publication Number:
  US 20080059226A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: A61J 1/1412 Containers with closing means, e.g. caps
• CPC Class Codes: A61J 2200/30 Compliance analysis for taking medication
• CPC Class Codes: A61J 7/0418 with electronic history memory
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 20/13 delivered from dispensers
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 80/00 ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Abstract

The subject invention provides systems and methods for monitoring prescription medications. In particular, systems and methods are provided for monitoring patient compliance with a given prescribed regimen as well as monitoring the origins of a prescription drug. The subject invention provides a central computer and a portable device, wherein the portable device includes at least one sensor for detecting a target marker. The target marker of the invention represents either the presence of a specific prescribed medication or identify the proper origins of a medication.

Claims

31. A method for monitoring patient compliance in taking a medication in accordance with a prescription regimen and tracking dispensed medication comprising:

a) providing information regarding a prescribed medication to a portable device and central computer;

b) distributing the prescribed medication to a patient;

c) exposing a sample of the patient'"'"'s bodily fluid to at least one sensor of the portable device; and

d) recording and analyzing data from the portable device,

wherein the at least one sensor is specific for at least one marker, wherein the prescribed medication comprises a first marker of the at least one marker, wherein said first marker is detectable in bodily fluids and is representative of the prescribed medication, and wherein said information comprises at least one item selected from the group consisting of;

information regarding the prescription regimen;

information regarding the first marker; and

information regarding the side effects of the prescription medication.

1. A system for monitoring patient compliance in taking a medication in accordance with a prescription regimen, tracking dispensed medication, and determining the origin of the prescribed medication, comprising:

a) a portable device comprising at least one sensor specific for at least one marker;

b) a prescribed medication comprising a first marker of the at least one marker, wherein said first marker is detectable in bodily fluids and is representative of the prescribed medication; and

c) a central computer that processes information provided by the portable device.

2. The system of claim 1, wherein the central computer comprises a first processing means that performs at least one of the following functions:

tracks dispensed prescription medication and corresponding prescription regimen;

tracks the markers that are detectable by the portable device; and

tracks information regarding the origin of the prescribed medication.

3. The system of claim 2, wherein the first processing means further comprises at least one of the items selected from the group consisting of a means for receiving data provided via the at least one sensor;

a means for determining whether an action has occurred within a configurable time interval;

a memory device;

a data filter;

a built-in algorithm;

an event indicator; and

an artificial neural network.

4. The system of claim 1, wherein the central computer is either directly or remotely connected to the portable device.

5. The system of claim 1, further comprising a communication device that can transfer data from the portable device to the central computer.

6. The system of claim 5, wherein the communication device is selected from the group consisting of:

wireless interfaces, cable modems, satellite links, microwave relays, and telephonic modems.

7. The system of claim 5, wherein the communication device permits two-way communication between the portable device and the central computer.

8. The system of claim 1, wherein the sensor is selected from the group consisting of surface acoustic wave sensors;

quartz microbalance sensors;

metal oxide sensors;

bulk acoustic wave sensors;

plate acoustic wave sensors;

interdigitated microelectrode sensors;

optical waveguide sensors;

electrochemical sensors;

electrically conducting sensors;

artificial noses;

electronic noses;

electronic tongues;

semiconductive gas sensors;

mass spectrometers;

IR, UV, visible, or fluorescence spectrophotometers;

apparatuses having conductive-polymer gas-fluorescence spectrophotometers;

sensors having conductive-polymer gas sensors;

aptamer-based biosensors;

ion mobility spectrometry;

photo-ionization detectors;

amplifying fluorescent polymer sensors;

ion mobility spectrometry;

thickness-shear mode sensors;

microgravimetric sensors;

molecularly imprinted polymer sensors;

surface resonance sensors; and

microcantilever sensors.

9. The system of claim 1, wherein the portable device further comprises a sampling means for providing a sample of the patient'"'"'s bodily fluid to the sensor of the portable device.

10. The system of claim 9, wherein the sampling means is selected from the group consisting of a wand, chamber, dish, plate, well assay, sheet, film, and dipstick.

11. The system of claim 1, wherein the bodily fluid is selected from the group consisting of exhaled breath, whole blood, blood plasma, urine, semen, saliva, lymph fluid, meningal fluid, amniotic fluid, glandular fluid, vaginal fluid, sputum, feces, sweat, mucuous, and cerebrospinal fluid.

12. The system of claim 11, wherein the bodily fluid is exhaled breath.

13. The system of claim 1, wherein the at least one marker is selected from the group consisting of the prescribed medication;

metabolites of the medication;

endogenous by-products produced in metabolizing the medication;

GRAS additives; and

olfactory markers.

14. The system of claim 13, wherein the GRAS additives are selected from the group consisting of dibenzyl ether;

difurfuryl ether;

ethylene glycol monobutyl ether;

furfuryl methyl ether;

isoeugenyl benzyl ether;

isoeugenyl ethyl ether;

isoeugenyl methyl ether;

methyl phenethyl ether;

beta-naphthyl isobutyl ether;

vanillyl butyl ether;

dimethylethanolamine;

isopentylideneisopentylamine;

sodium bisulfate;

dioctyl sodium sulfosuccinate;

polyglycerol polyricinoleic acid;

calcium casein peptone-calcium phosphate;

botanicals;

ferrous bisglycinate chelate;

seaweed-derived calcium;

docosahexaenoic acid-rich single cell oil;

arachidonic acid-rich single-cell oil;

frucooligosaccharide;

trehalose;

gamma cyclodextrin;

phytosterol esters;

gum arabic;

potassium bisulfate;

stearyl alcohol;

erythritol;

D-tagatose; and

mycoprotein.

15. The system of claim 14, wherein the botanicals are selected from the group consisting of chrysanthemum;

licorice;

jellywort;

honeysuckle;

lophatherum;

mulberry leaf;

frangipani;

selfheal; and

sophora flower bud.

16. The system of claim 13, wherein the olfactory markers are selected from the group consisting of dimethyl sulfoxide;

acetaldehyde;

acetophenone;

trans-Anethole (1-methoxy-4-propenyl benzene) (anise);

benzaldehyde (benzoic aldehyde);

benzyl alcohol;

benzyl cinnamate;

cadinene;

camphene;

camphor;

cinnamaldehyde (3-phenylpropenal);

garlic;

citronellal;

cresol;

cyclohexane;

eucalyptol;

eugenol, eugenyl methyl ether;

butyl isobutyrate (n-butyl 2, methyl propanoate) (pineapple);

citral (2-trans-3,7-dimethyl-2,6-actadiene-1-al);

menthol (1-methyl-4-isopropylcyclohexane-3-ol); and

α

-Pinene (2,6,6-trimethylbicyclo-(3,1,1)-2-heptene).

17. The system of claim 13, where the first marker is the prescribed medication, the prescribed medication further comprising compounds that enhance detection of the markers by the sensor of the portable device.

18. The system of claim 1, wherein the prescribed medication is selected from the group consisting of narcotic analgesics;

narcotic analgesics in combination with other medications;

medications to treat various mental conditions or disorders;

medications for treating erectile dysfunction, medications for treating weight problems;

cerebral nervous system depressants;

medications to treat diarrhea; and

stimulants.

19. The system of claim 18, wherein the prescribed medication is selected from the group consisting of Darvon, Demerol, Dilaudid, Fentanyl, Methadose, MSIR, Nubain, Oxycontin, Roxanol, Stadol, Vicodin;

Lorcet;

Tylox;

Percocet, Diazepam, Paroxetine, Sertraline, Fluoxetine, Viagra, Mebaral, Nembutal, Librium, Xanax, Halcion, ProSom, Adderal;

Dexedrine, Ritalin;

Focalin; and

Provigil.

20. The system of claim 1, wherein the portable device further comprises a second processing means for processing the signals generated by the sensor.

21. The system of claim 20, wherein the second processing means further comprises at least one of the items selected from the group consisting of a means for receiving data provided via the at least one sensor;

a means for determining whether an action has occurred within a configurable time interval;

a memory device;

a data filter;

a built-in algorithm;

an event indicator; and

an artificial neural network.

22. The system of claim 21, wherein the second processing means executes program codes that coordinate various operations of the portable device.

23. The system of claim 22, wherein at least one of the program codes are selected from the group consisting of interaction software;

analysis of bodily fluid software; and

calendar software.

24. The system of claim 1, wherein the portable device further comprises an identification system.

25. The system of claim 24, wherein the identification system is selected from the group consisting of a biometric identification system, an electronic coding system, and a lock-and-key identification system.

26. The system of claim 1, wherein the portable device further comprises at least one of the items selected from the group consisting of an input means and a display means.

27. The system of claim 1, wherein the items are selected from the group consisting of an input device;

an interactive graphical monitor;

a liquid crystal display; and

a monitor.

28. The system of claim 1, wherein the portable device is designed using modular sections.

29. The system of claim 1, further comprising a medication container for said prescribed medication, the medication container comprising a second marker, wherein said second marker is indicative of the origins of the prescribed medication.

30. The system of claim 29, wherein said second marker is detectable in the headspace of the container, on a component of said container, or on a packaging item of the container.

32. The method of claim 31, wherein information regarding the prescription regimen;

information regarding the first marker; and

information regarding the side effects of the prescription medication are provided to the central computer, wherein the central computer comprises a first processing means that performs at least one of the following functions;

tracks dispensed prescription medication and corresponding prescription regimen; and

tracks the markers that are detectable by the portable device.

33. The method of claim 32, wherein the first processing means further comprises at least one of the items selected from the group consisting of a means for receiving data provided via the at least one sensor;

a means for determining whether an action has occurred within a configurable time interval;

a memory device;

a data filter;

a built-in algorithm;

an event indicator; and

an artificial neural network.

34. The method of claim 31, wherein the central computer is either directly or remotely connected to the portable device.

35. The method of claim 31, wherein the central computer further comprises a communication device that can transfer data from the portable device to the central computer.

36. The method of claim 35, wherein the communication device is selected from the group consisting of:

wireless interfaces, cable modems, satellite links, microwave relays, and telephonic modems.

37. The method of claim 35, wherein the communication device permits two-way communication between the portable device and the central computer.

38. The method of claim 31, wherein the sensor is selected from the group consisting of surface acoustic wave sensors;

quartz microbalance sensors;

metal oxide sensors;

bulk acoustic wave sensors;

plate acoustic wave sensors;

interdigitated microelectrode sensors;

optical waveguide sensors;

electrochemical sensors;

electrically conducting sensors;

artificial noses;

electronic noses;

electronic tongues;

semiconductive gas sensors;

mass spectrometers;

IR, UV, visible, or fluorescence spectrophotometers;

apparatuses having conductive-polymer gas-fluorescence spectrophotometers;

sensors having conductive-polymer gas sensors;

aptamer biosensors;

ion mobility spectrometry;

photo-ionization detectors;

amplifying fluorescent polymer sensors;

ion mobility spectrometry;

thickness-shear mode sensors;

microgravimetric sensors;

molecularly imprinted polymer sensors;

surface resonance sensors; and

microcantilever sensors.

39. The method of claim 31, wherein the portable device further comprises a sampling means for exposing the sample of the patient'"'"'s bodily fluid to the sensor of the portable device.

40. The method of claim 39, wherein the sampling means is selected from the group consisting of a wand, chamber, dish, plate, well assay, sheet, film, and dipstick.

41. The method of claim 31, wherein the bodily fluid sample is selected from the group consisting of exhaled breath, whole blood, blood plasma, urine, semen, saliva, lymph fluid, meningal fluid, amniotic fluid, glandular fluid, vaginal fluid, sputum, feces, sweat, mucuous, and cerebrospinal fluid.

42. The method of claim 41, wherein the bodily fluid is exhaled breath and further comprising the steps of:

administering the prescribed medication to the patient;

after administration of the medication, and providing the sample of exhaled breath to the at least one sensor of the portable device.

43. The method of claim 31, wherein the at least one marker is selected from the group consisting of the prescribed medication;

metabolites of the medication;

endogenous by-products produced in metabolizing the medication;

GRAS additives; and

olfactory markers.

44. The method of claim 43, wherein the GRAS additives are selected from the group consisting of dibenzyl ether;

difurfuryl ether;

ethylene glycol monobutyl ether;

furfuryl methyl ether;

isoeugenyl benzyl ether;

isoeugenyl ethyl ether;

isoeugenyl methyl ether;

methyl phenethyl ether;

beta-naphthyl isobutyl ether;

vanillyl butyl ether;

dimethylethanolamine;

isopentylideneisopentylamine;

sodium bisulfate;

dioctyl sodium sulfosuccinate;

polyglycerol polyricinoleic acid;

calcium casein peptone-calcium phosphate;

botanicals;

ferrous bisglycinate chelate;

seaweed-derived calcium;

docosahexaenoic acid-rich single cell oil;

arachidonic acid-rich single-cell oil;

frucooligosaccharide;

trehalose;

gamma cyclodextrin;

phytosterol esters;

gum arabic;

potassium bisulfate;

stearyl alcohol;

erythritol;

D-tagatose; and

mycoprotein.

45. The method of claim 44, wherein the botanicals are selected from the group consisting of chrysanthemum;

licorice;

jellywort;

honeysuckle;

lophatherum;

mulberry leaf;

frangipani;

selfheal; and

sophora flower bud.

46. The method of claim 43, wherein the olfactory markers are selected from the group consisting of dimethyl sulfoxide;

acetaldehyde;

acetophenone;

trans-Anethole (1-methoxy-4-propenyl benzene) (anise);

benzaldehyde (benzoic aldehyde);

benzyl alcohol;

benzyl cinnamate;

cadinene;

camphene;

camphor;

cinnamaldehyde (3-phenylpropenal);

garlic;

citronellal;

cresol;

cyclohexane;

eucalyptol;

eugenol, eugenyl methyl ether;

butyl isobutyrate (n-butyl 2, methyl propanoate) (pineapple);

citral (2-trans-3,7-dimethyl-2,6-actadiene-1-al);

menthol (1-methyl-4-isopropylcyclohexane-3-ol); and

α

-Pinene (2,6,6-trimethylbicyclo-(3,1,1)-2-heptene).

47. The method of claim 43, where the first marker is the prescribed medication, the prescribed medication further comprising compounds that enhance detection of the markers by the sensor of the portable device.

48. The method of claim 31, wherein the prescribed medication is selected from the group consisting of narcotic analgesics;

narcotic analgesics in combination with other medications;

medications to treat various mental conditions or disorders;

medications for treating erectile dysfunction, medications for treating weight problems;

cerebral nervous system depressants;

medications to treat diarrhea; and

stimulants.

49. The method of claim 48, wherein the prescribed medication is selected from the group consisting of Darvon, Demerol, Dilaudid, Fentanyl, Methadose, MSIR, Nubain, Oxycontin, Roxanol, Stadol, Vicodin;

Lorcet;

Tylox;

Percocet, Diazepam, Paroxetine, Sertraline, Fluoxetine, Viagra, Mebaral, Nembutal, Librium, Xanax, Halcion, ProSom, Adderal;

Dexedrine, Ritalin;

Focalin; and

Provigil.

50. The method of claim 31, wherein the portable device further comprises a second processing means for processing the signals generated by the sensor.

51. The method of claim 50, wherein the second processing means further comprises at least one of the items selected from the group consisting of a means for receiving data provided via the at least one sensor;

a means for determining whether an action has occurred within a configurable time interval;

a memory device;

a data filter;

a built-in algorithm;

an event indicator; and

an artificial neural network.

52. The method of claim 51, wherein the second processing means executes program codes that coordinate various operations of the portable device.

53. The method of claim 52, wherein at least one of the program codes are selected from the group consisting of interaction software;

analysis of bodily fluid software; and

calendar software.

54. The method of claim 31, wherein the portable device further comprises an identification system.

55. The method of claim 54, wherein the identification system is selected from the group consisting of a biometric identification system, an electronic coding system, and a lock-and-key identification system.

56. The method of claim 55, wherein the identification system is the biometric identification system, and further comprising the step of supplying a biometric feature to the biometric identification system prior to exposing the sample of patient bodily fluid to the at least one sensor of the portable device.

56-1. The method of claim 31, wherein the portable device is designed using modular sections.

57. A method for determining the origin of a prescription medication comprising:

a) providing information regarding a prescribed medication'"'"'s origin to a portable device and central computer;

b) exposing an area of a medication container to at least one sensor of the portable device;

d) recording and analyzing data from the portable device,

wherein the at least one sensor is specific for at least one marker, wherein the medication container comprises a first marker of the at least one marker, wherein said first marker is representative of the prescribed medication'"'"'s origin, and wherein said information comprises information regarding the first marker.

58. The method of claim 57, wherein the area of the medication container is selected from the group consisting of:

a headspace, a cap, and a packaging item.

59. The method of claim 57, wherein information regarding the information regarding the first marker is provided to the central computer, wherein the central computer comprises a first processing means that tracks the information regarding the origin of the prescribed medication.

60. The method of claim 57, wherein the central computer is either directly or remotely connected to the portable device.

61. The method of claim 57, wherein the central computer further comprises a communication device that enables communication to the central computer.

62. The method of claim 61, wherein the communication device is selected from the group consisting of:

wireless interfaces, cable modems, satellite links, microwave relays, and telephonic modems.

63. The method of claim 61, wherein the communication device permits two-way communication between the portable device and the central computer.

64. The method of claim 57, wherein the sensor is selected from the group consisting of surface acoustic wave sensors;

quartz microbalance sensors;

metal oxide sensors;

bulk acoustic wave sensors;

plate acoustic wave sensors;

interdigitated microelectrode sensors;

optical waveguide sensors;

electrochemical sensors;

electrically conducting sensors;

artificial noses;

electronic noses;

electronic tongues;

semiconductive gas sensors;

mass spectrometers;

IR, UV, visible, or fluorescence spectrophotometers;

apparatuses having conductive-polymer gas-fluorescence spectrophotometers;

sensors having conductive-polymer gas sensors;

aptamer biosensors;

ion mobility spectrometry;

photo-ionization detectors;

amplifying fluorescent polymer sensors;

ion mobility spectrometry;

thickness-shear mode sensors;

microgravimetric sensors;

molecularly imprinted polymer sensors;

surface resonance sensors; and

microcantilever sensors.

65. The method of claim 57, wherein the at least one marker is selected from the group consisting of the prescribed medication;

GRAS additives; and

olfactory markers.

66. The method of claim 65, wherein the GRAS additives are selected from the group consisting of dibenzyl ether;

difurfuryl ether;

ethylene glycol monobutyl ether;

furfuryl methyl ether;

isoeugenyl benzyl ether;

isoeugenyl ethyl ether;

isoeugenyl methyl ether;

methyl phenethyl ether;

beta-naphthyl isobutyl ether;

vanillyl butyl ether;

dimethylethanolamine;

isopentylideneisopentylamine;

sodium bisulfate;

dioctyl sodium sulfosuccinate;

polyglycerol polyricinoleic acid;

calcium casein peptone-calcium phosphate;

botanicals;

ferrous bisglycinate chelate;

seaweed-derived calcium;

docosahexaenoic acid-rich single cell oil;

arachidonic acid-rich single-cell oil;

frucooligosaccharide;

trehalose;

gamma cyclodextrin;

phytosterol esters;

gum arabic;

potassium bisulfate;

stearyl alcohol;

erythritol;

D-tagatose; and

mycoprotein.

67. The method of claim 66, wherein the botanicals are selected from the group consisting of chrysanthemum;

licorice;

jellywort;

honeysuckle;

lophatherum;

mulberry leaf;

frangipani;

selfheal; and

sophora flower bud.

68. The method of claim 65, wherein the olfactory markers are selected from the group consisting of dimethyl sulfoxide;

acetaldehyde;

acetophenone;

trans-Anethole (1-methoxy-4-propenyl benzene) (anise);

benzaldehyde (benzoic aldehyde);

benzyl alcohol;

benzyl cinnamate;

cadinene;

camphene;

camphor;

cinnamaldehyde (3-phenylpropenal);

garlic;

citronellal;

cresol;

cyclohexane;

eucalyptol;

eugenol, eugenyl methyl ether;

butyl isobutyrate (n-butyl 2, methyl propanoate) (pineapple);

citral (2-trans-3,7-dimethyl-2,6-actadiene-1-al);

menthol (1-methyl-4-isopropylcyclohexane-3-ol); and

α

-Pinene (2,6,6-trimethylbicyclo-(3,1,1)-2-heptene).

69. The method of claim 57, wherein the portable device further comprises a second processing means for processing the signals generated by the sensor.

70. The method of claim 69, wherein the second processing means further comprises at least one of the items selected from the group consisting of a means for receiving data provided via the at least one sensor;

a means for determining whether an action has occurred within a configurable time interval;

a memory device;

a data filter;

a built-in algorithm;

an event indicator; and

an artificial neural network.

71. The method of claim 69, wherein the second processing means executes program codes that coordinate various operations of the portable device.

72. The method of claim 71, wherein at least one of the program codes are selected from the group consisting of interaction software;

analysis of the marker software; and

calendar software.

73. The method of claim 57, wherein the portable device is designed using modular sections.